LAG-3 Archives - Medical Conferences

Relatlimab addition benefits only a subgroup of metastatic NSCLC

Presented By

Prof. Nicolas Girard, Institut Curie, France

Trial

Phase 2, RELATIVITY-104

Conference

ESMO 2024

Type

Peer-reviewed article

4 November 2024 12:11

Presented By

Dr Yara Verschoor, Netherlands Cancer Institute, the Netherlands

Trial

Phase 2, NICHE-3

Conference

ESMO 2023

Type

Peer-reviewed article

18 December 2023 16:04

Presented By

Dr Evan Lipson, Johns Hopkins University, MD, USA

Trial

Phase 3, RELATIVITY-047

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 22:14

Presented By

Dr Rodabe Amaria , MD Anderson Cancer Center, TX, USA

Trial

Phase 2

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 12:16

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 12:43